- Home
- PRAX vs RZLV Comparison
PRAX vs RZLV Comparison
Compare PRAX & RZLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- RZLV
- Stock Information
- Founded
- PRAX 2015
- RZLV 2016
- Country
- PRAX United States
- RZLV United Kingdom
- Employees
- PRAX N/A
- RZLV N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- RZLV
- Sector
- PRAX Health Care
- RZLV
- Exchange
- PRAX Nasdaq
- RZLV NYSE
- Market Cap
- PRAX 599.7M
- RZLV 514.1M
- IPO Year
- PRAX 2020
- RZLV N/A
- Fundamental
- Price
- PRAX $42.34
- RZLV $1.92
- Analyst Decision
- PRAX Strong Buy
- RZLV Strong Buy
- Analyst Count
- PRAX 11
- RZLV 5
- Target Price
- PRAX $114.73
- RZLV $5.20
- AVG Volume (30 Days)
- PRAX 294.2K
- RZLV 3.5M
- Earning Date
- PRAX 08-12-2025
- RZLV 02-21-2025
- Dividend Yield
- PRAX N/A
- RZLV N/A
- EPS Growth
- PRAX N/A
- RZLV N/A
- EPS
- PRAX N/A
- RZLV N/A
- Revenue
- PRAX $8,122,000.00
- RZLV $187,788.00
- Revenue This Year
- PRAX N/A
- RZLV $18,916.66
- Revenue Next Year
- PRAX $6,358.50
- RZLV $175.14
- P/E Ratio
- PRAX N/A
- RZLV N/A
- Revenue Growth
- PRAX 270.02
- RZLV 29.46
- 52 Week Low
- PRAX $26.70
- RZLV $1.07
- 52 Week High
- PRAX $91.83
- RZLV $12.29
- Technical
- Relative Strength Index (RSI)
- PRAX 54.36
- RZLV N/A
- Support Level
- PRAX $41.64
- RZLV N/A
- Resistance Level
- PRAX $44.99
- RZLV N/A
- Average True Range (ATR)
- PRAX 2.55
- RZLV 0.00
- MACD
- PRAX -0.11
- RZLV 0.00
- Stochastic Oscillator
- PRAX 51.07
- RZLV 0.00
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About RZLV REZOLVE AI LTD
Rezolve AI PLC is an AI-powered solutions company, specializing in enhancing customer engagement, operational efficiency, and revenue growth for the retail and e-commerce sectors. The company's product, Brain Commerce, powered by its proprietary Large Language Model (LLM) brainpowa, transforms the online shopping experience. By surpassing traditional site search and product discovery tools, Brain Commerce improves conversion rates, increases average order value (AOV), and reduces cart abandonment. The company has one reportable segment, which is cloud-based services. Geographically, the company generates revenue from Canada, the United States, Mexico, Australia, the United Kingdom, and Japan, with the majority of revenue generated from the United States.